Nexus BioPharma
Dan Einhorn, M.D. is medical director of the Scripps Whittier Diabetes Institute, clinical professor of medicine (voluntary) at UC San Diego, president of Diabetes and Endocrine Associates, and associate editor of the Journal of Diabetes.
Dr. Einhorn’s experience includes acting as a trustee and past-president of the American College of Endocrinology (ACE), a founding member and current regent of the ACE Foundation, and past-president of the American Association of Clinical Endocrinologists (AACE).
Dr. Einhorn received his BA at Yale (Summa cum Laude), his MD at Tufts (AOA) and his post-graduate training at Harvard.
He has been in leadership at AACE and ACE for over 20 years during which time he has participated in writing many national guidelines, including those for diabetes, pre-diabetes, inpatient diabetes management, and obesity.
Dr. Einhorn has been on the teaching faculty of every AACE/ACE annual meeting since 1994, chairing the meeting in 2009, and he continues to be a practicing physician.
He has devoted his practice exclusively to the care of adults with endocrine disorders, including diabetes, thyroid disease, osteoporosis, lipid disorders, polycystic ovarian syndrome, adrenal disease, parathyroid disease and diagnostic dilemmas that may have a hormonal origin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Nexus BioPharma
This company is a preclinical stage biotechnology company developing new therapies and intellectual property.